CD4 and neoplasm: Initial studies suggested that CD4+ and CD8+ T cells mediated GM-CSF-stimulated antitumor immunity, but recent models using CD1d deficient mice support a critical role for NKT cells in GM-CSF anti-tumor immune responses.